FIM
LGND icon

Freedom Investment Management’s Ligand Pharmaceuticals LGND Stock Holding History

Freedom Investment Management’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,169
Closed -$206K – 894
2021
Q1 		$206K Buy
+2,169
New +$205K 0.02% 784
2019
Q2 		– Sell
-5,090
Closed -$399K – 714
2019
Q1 		$399K Buy
+5,090
New +$386K 0.03% 439
2018
Q2 		– Sell
-13,815
Closed -$1.42M – 1040
2018
Q1 		$1.42M Buy
13,815
+215
+2% +$21.3K 0.07% 267
2017
Q4 		$1.16M Buy
13,600
+431
+3% +$37.4K 0.06% 306
2017
Q3 		$1.12M Sell
13,169
-631
-5% -$50K 0.06% 298
2017
Q2 		$1.04M Buy
13,800
+82
+0.6% +$5.74K 0.06% 300
2017
Q1 		$906K Sell
13,718
-3,673
-21% -$242K 0.05% 327
2016
Q4 		$1.1M Sell
17,391
-2,813
-14% -$178K 0.07% 214
2016
Q3 		$1.29M Buy
20,204
+17
+0.1% +$1.25K 0.08% 177
2016
Q2 		$1.5M Buy
20,187
+1,113
+6% +$82.6K 0.1% 121
2016
Q1 		$1.27M Buy
+19,074
New +$1.16M 0.09% 163

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Freedom Investment Management's LGND Position: Q2 2021 in Review

Freedom Investment Management sold out of Ligand Pharmaceuticals (LGND) in Q2 2021, closing a stake of 2,169 shares — an estimated $206K sold.

Freedom Investment Management first reported a position in LGND in Q1 2016 and held it in 11 quarters. The position peaked at $1.5M in Q2 2016. 212 funds tracked by Wall St. Rank hold LGND as of Q2 2021.

  • Freedom Investment Management reported no remaining Ligand Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Freedom Investment Management sold 2,169 Ligand Pharmaceuticals shares in Q2 2021, an estimated $206K.
  • Freedom Investment Management first reported a position in Ligand Pharmaceuticals in Q1 2016 and held it in 11 quarters.
  • Freedom Investment Management's Ligand Pharmaceuticals position peaked at $1.5M in Q2 2016.
  • 212 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2021.

Based on Freedom Investment Management's 13F filing for Q2 2021, filed 12 Aug 2021.